Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality.
A patient with a lymphoproliferative disorder, angioedema, and an acquired deficiency of the inhibitor of the activated first component of complement was studied. The patient's complement profile revealed depletion of the first component of complement, which has not been seen in angioedema of the hereditary type. There was no evidence for C1-depleting activity in the patient's plasma. The majority of the patient's peripheral blood mononuclear cells resembled B cells in their memebrane receptor properties and in that they carried easily detectable immunoglobulin, predominantly IgM. However, these cells were unusual in that they phagocytosed both latex particles and C3-coated erythrocytes. Morphological study of the cells infiltrating the patient's lung revealed immature, atypical, and plasmacytoid lymphocytes and immunoblasts. Both the patient's peripheral blood mononuclear cells and a suspension of cells from the pulmonary infiltrate were capable of depleting the first component of complement and its inhibitor from homologous plasma. Normal ABO-compatible cells did not possess this property. The data suggested that the patient's abnormal lymphoid cells may have interacted with the complement system to produce a biochemical defect and a clinical syndrome closely resembling angioedema of the hereditary type.
D000368:Aged; D000799:Angioedema / Q000097:blood / Q000150:complications / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D003172:Complement C1 / Q000172:deficiency; D003174:Complement C1 Inactivator Proteins; D003169:Complement Inactivator Proteins; D006801:Humans; D008168:Lung / Q000648:ultrastructure; D008206:Lymphatic Diseases / Q000097:blood / Q000150:complications / Q000276:immunology*; D008297:Male; D009000:Monocytes / Q000276:immunology
D003172:Complement C1; D003174:Complement C1 Inactivator Proteins; D003169:Complement Inactivator Proteins